Editorial: Immune-checkpoint inhibitors in anti-cancer armamentarium: a double-edged sword in risk of developing autoimmunity and immune-related adverse effects

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2024-08, Vol.14, p.1476475
Main Authors: Tulunay Virlan, Aysin, Cafaro, Giacomo, Sunzini, Flavia, Degboe, Yannick, Christodoulou, Maria-Ioanna
Format: Article
Language:English
Subjects:
anti-CTLA-4
anti-PD-1/PD-L1
autoimmunity
cancer immunotherapy
immune-checkpoint inhibitors (ICIs)
immune-related adverse events (irAEs)
Oncology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2024.1476475